TRP-TriptansTryptophan Levels and Triptan Effectiveness in Migraine Patients
Data Collection
Collected at a single point in time - Cross-sectionalBrain Diseases+3
+ Central Nervous System Diseases
+ Migraine Disorders
Case-Control
Comparing exposures between individuals with and without disease in order to identify potential risk factors.Summary
Study start date: November 1, 2025
Actual date on which the first participant was enrolled.Migraine is a significant health issue affecting people worldwide, leading to significant disability. Triptans are commonly used medications that help alleviate the pain and symptoms of migraines by affecting blood vessels and reducing inflammation. Despite their effectiveness, not all patients experience relief from triptans. This study focuses on understanding why some people do not respond well to these medications. It investigates the role of tryptophan, an essential amino acid, in influencing the effectiveness of triptans. Since tryptophan contributes to the production of important chemicals like serotonin, which are involved in managing migraines, understanding its role could help improve treatment for those who currently find triptans ineffective. The study observes patients with migraines to compare tryptophan levels in those who respond well to triptans and those who do not. Participants' blood samples are analyzed to measure tryptophan and its by-products. For those undergoing a lumbar puncture as part of their regular care, cerebrospinal fluid is also examined. Additionally, the study explores the potential link between tryptophan metabolism and conditions like inflammatory bowel disease, which could affect how the body absorbs and processes tryptophan. By identifying these connections, the study aims to enhance understanding and treatment options for migraine sufferers.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.144 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Case-Control
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 50 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location